These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27050021)

  • 61. Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost.
    Tandon N; Balart LA; Laliberté F; Pilon D; Lefebvre P; Germain G; Prabhakar A
    J Med Econ; 2014 Dec; 17(12):862-71. PubMed ID: 25215925
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Feldman DI; Valero-Elizondo J; Salami JA; Rana JS; Ogunmoroti O; Osondu CU; Spatz ES; Virani SS; Blankstein R; Blaha MJ; Veledar E; Nasir K
    Atherosclerosis; 2017 Mar; 258():79-83. PubMed ID: 28214425
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    Pourcher V; Gourmelen J; Bureau I; Bouee S
    PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Economic evaluation of the societal costs of hepatitis B in South Korea.
    Yang BM; Paik SW; Hahn OS; Yi DH; Choi MS; Payne S
    J Gastroenterol Hepatol; 2001 Mar; 16(3):301-8. PubMed ID: 11339422
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The current total economic burden of diabetes mellitus in the Netherlands.
    Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
    Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Costs and utilization of treatment in patients with hemophilia.
    Rocha P; Carvalho M; Lopes M; Araújo F
    BMC Health Serv Res; 2015 Oct; 15():484. PubMed ID: 26502954
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased risk of hepatitis B virus infection amongst individuals with diabetes mellitus.
    Zhang X; Zhu X; Ji Y; Li H; Hou F; Xiao C; Yuan P
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30858308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Health service utilization and related costs attributable to diabetes.
    O'Neill KN; McHugh SM; Tracey ML; Fitzgerald AP; Kearney PM
    Diabet Med; 2018 Dec; 35(12):1727-1734. PubMed ID: 30153351
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Direct service costs of diabetes mellitus hospitalisations in the Mexican Institute of Social Security].
    Salas-Zapata L; Palacio-Mejía LS; Aracena-Genao B; Hernández-Ávila JE; Nieto-López ES
    Gac Sanit; 2018; 32(3):209-215. PubMed ID: 27495830
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Estimated hospitalizations attributable to diabetes mellitus within the public healthcare system in Brazil from 2008 to 2010: study DIAPS 79.
    Rosa R; Nita ME; Rached R; Donato B; Rahal E
    Rev Assoc Med Bras (1992); 2014; 60(3):222-30. PubMed ID: 25004267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The TransFORmation of IndiGEnous PrimAry HEAlthcare Delivery (FORGE AHEAD): economic analysis.
    Stanimirovic A; Francis T; Webster-Bogaert S; Harris S; Rac V;
    Health Res Policy Syst; 2024 May; 22(1):57. PubMed ID: 38741196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data.
    Huang Y; Vemer P; Zhu J; Postma MJ; Chen W
    PLoS One; 2016; 11(8):e0159297. PubMed ID: 27570976
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland.
    McLernon DJ; Donnan PT; Dillon JF
    Epidemiol Infect; 2013 Oct; 141(10):2122-30. PubMed ID: 23200407
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus.
    Wu T; Yang F; Chan WWL; Lam CLK; Wong CKH
    J Diabetes Investig; 2020 Nov; 11(6):1661-1672. PubMed ID: 32471010
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Societal costs of diabetes mellitus in Denmark.
    Sortsø C; Green A; Jensen PB; Emneus M
    Diabet Med; 2016 Jul; 33(7):877-85. PubMed ID: 26414087
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [HBV-infections in Germany - health care costs in a real-life-setting].
    Stahmeyer JT; Becker H; Orlemann AL; Krauth C; Manns MP; Wedemeyer H
    Z Gastroenterol; 2017 Nov; 55(11):1103-1112. PubMed ID: 29141265
    [No Abstract]   [Full Text] [Related]  

  • 78. Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications.
    Cheng SW; Wang CY; Ko Y
    J Diabetes Res; 2019; 2019():2363292. PubMed ID: 31583247
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cost of diabetes care in out-patient clinics of Karachi, Pakistan.
    Khowaja LA; Khuwaja AK; Cosgrove P
    BMC Health Serv Res; 2007 Nov; 7():189. PubMed ID: 18028552
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The societal burden of HBV-related disease: South Korea.
    Yang BM; Kim DJ; Byun KS; Kim HS; Park JW; Shin S
    Dig Dis Sci; 2010 Mar; 55(3):784-93. PubMed ID: 19333757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.